Julie M. Vose, MD, MBA, FASCO, president of the American Society of Clinical Oncology (ASCO), and keynote speaker at this year's Patient-Centered Oncology Care meeting, discusses addressing cost of care, using value calculators, and the Medicare Access and CHIP Reauthorization Act.
Julie M. Vose, MD, MBA, FASCO, president of the American Society of Clinical Oncology (ASCO), and keynote speaker at this year's Patient-Centered Oncology Care meeting, discusses addressing cost of care, using value calculators, and the Medicare Access and CHIP Reauthorization Act.
Transcript (slightly modified)
How does ASCO's Value Framework help to address cost of care?
ASCO Value Framework really takes it back to what we really do for patients. Right now what happens is the cost of the drug has to cover the cost of a lot of what we do for patients that are not reimbursed. This really takes back so the cost of getting the patient information, the of following up on the patient, the cost of clinical trials, all those costs that are currently not covered are helped by this new Value Framework in trying to make sure that we can improve that outcome for patients.
What is the importance of value calculators being created and how can they be incorporated into shared decision making?
The information that we give to patients right now has very little cost information, so the value calculators try to put together what's the outcome for that specific regimen or treatment. What's the cost of that drug? What are the side effects of those drugs? And compares it to a standard of care and that way it helps the patient and the physician to have shared decision making.
What does the Medicare Access and CHIP Reauthorization Act (MACRA) get right and what could be improved upon?
Well I think MACRA gets right that we should move away from fee-for-service. I think we need to be able to make sure we can provide care to patients in an organized fashion, quality-based, but not necessarily having it in a fee-for-service fashion as some unintended consequences sometimes are you get paid for what you do. I think that part is right, it's just a matter of how do we define that, how do we improve upon that to make sure that we can still get everything paid for.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More